Dr Lalchandani Labs Ltd vs Indraprastha Medical Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.95 as of 29 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Indraprastha Medical Corporation Ltd changed from 215 on March 2021 to 18.5 on March 2026 . This represents a CAGR of -33.56% over 6 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 6.02 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 492.74 crore on March 2021 to ₹ 3407 crore on March 2026 . This represents a CAGR of 38.03% over 6 years The revenue of Dr Lalchandani Labs Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Indraprastha Medical Corporation Ltd for the Sep '26 is ₹ 421.4 crore as compare to the Jun '26 revenue of ₹ 414.57 crore. This represent the growth of 1.65% The ebitda of Dr Lalchandani Labs Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Indraprastha Medical Corporation Ltd for the Sep '26 is ₹ 85.99 crore as compare to the Jun '26 ebitda of ₹ 88.23 crore. This represent the decline of -2.54% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 44.77 crore to ₹ 53.58 crore over 10 quarters. This represents a CAGR of 7.45% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Indraprastha Medical Corporation Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Indraprastha Medical Corporation Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Indraprastha Medical Corporation Ltd is 2,797 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Indraprastha Medical Corporation Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Indraprastha Medical Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Indraprastha Medical Corporation Ltd?

As of October 31, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.95. On the other hand, Indraprastha Medical Corporation Ltd stock price is INR ₹305.15.

How do dividend payouts of Dr Lalchandani Labs Ltd and Indraprastha Medical Corporation Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Indraprastha Medical Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.